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Abstract
Background: Hemangiomas are the most common type of congenital anomaly in childhood.
Although many resolve spontaneously, intervention is required when their growth could damage
vital adjacent structures. Various therapeutic approaches to childhood hemangiomas with different
types of laser have been described previously. The objective of this study was to determine
whether the cooling of the epidermis during irradiation of hemangiomas with a Nd:YAG laser
prevents thermal damage and decreases the number of sessions required to treat these lesions.
Methods: Between 1993 and 2001, 110 patients aged 3 months to 4 years, with cutaneous
hemangiomas were treated with a Nd:YAG laser. The lesion was cooled with ice prior to, during,
and after the irradiation. During each session the laser beam passed through the pieces of ice. The
laser power was between 35–45 W with a pulse length of 2–10 seconds.
Results: After 6 months of follow-up, from the first session of laser treatment, total resolution
was obtained in 72 (65.5%) patients. A second or third session followed in 30 out of 38 patients in
which, the initial results were good, moderate, or poor. The parents of the remaining eight children
refused this second session and these patients excluded from the study Complications were seen
in nine (8.8%) patients. One patient had postoperative bleeding which stopped spontaneously, while
atrophic scars occurred in six (5.8%) patients, and hypertrophic scars in two (1.9%) patients.
Conclusions: Nd:YAG laser irradiation in conjunction with ice protection of the epidermis
produces good cosmetic results for the treatment of cutaneous hemangiomas in children, and
decreases the number of sessions for treatment of these lesions.
Background
A hemangioma is a benign congenital vascular malforma-
tion and the most common type of tumor in infancy. It
has been reported that 1.1 – 2.6% of newborns suffer
from this vascular lesion, and this number increases to
10.1% by 12 months of age [1]. They are usually absent at
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life, and often continue to grow until 12 months of age.
After this proliferative phase, slow involution follows in
most cases, with almost complete disappearance by 5–10
years of age [2–4]. However, in 10 – 20% of cases with cu-
taneous hemangioma, complications appear such as ul-
ceration and bleeding, and the involvement of important
functions such as vision, respiration, hearing, or feeding.
These complications, along with cosmetic disfigurement,
are a clear indication for treatment and should immedi-
ately lead to a suitable therapy [4–8]. Although laser irra-
diation has been used to induce photo-thermal
destruction of hemangiomas, thermal damage to the epi-
dermis remains a concern [6,9,10]. The objective of this
study was to determine the efficacy of combining Nd:YAG
photocoagulation with the protective use of ice for defin-
itive treatment of hemangiomas in the pediatric
population.
Methods
From January 1993 to December 2001, 110 patients with
cutaneous hemangiomas were treated in our department
with a Nd:YAG laser (Neodym:YAG laser, MCW 100,
1989 Germany, Aesculap). Eight-two (74.5%) were fe-
male, and 28 (25.5%) were male, and their ages ranged
from 3 months to 4 years with a mean age of 9 months. In
all cases the diagnosis of hemangiomas was confirmed
clinically. The anatomic location of the hemangiomas var-
ied, such as on the cheek, flank, scalp, torso, shoulder,
hand, lip, forehead, eyelid, eyebrow, and nose. All the pa-
tients in this study did not receive any other treatments
such as steroids, interferon, e.c.t. Preoperative evaluation
in all 110 patients included medical history, a complete
physical examination, and blood count (i.e., hematocrit
and, platelet count). The indications for treatment were as
follows: in 72 (65.5%) patients the hemangioma had af-
fected a vital function such as, vision, respiration, hearing,
or feeding; in 25 (22.7%) patients there was recurrent ul-
ceration and hemorrhage; and in 13 (11.8%) patients sig-
nificant cosmetic disfigurement and psychological
problems related to appearance were present. Each he-
mangioma was categorized after measuring its length,
width, and height. On the basis of area (length × width)
they were divided into three categories: (a) 1 to 4 cm2, (b)
4 to 10 cm2, and (c) greater than 10 cm2; on the basis of
height, they were divided into three categories: (A) 1 to 2
cm, (B) 2 to 3 cm, and (C) greater than 3 cm. Table 1
shows the patient allocations on these bases. Lesions were
measured in cube centimeters and recorded in a database.
All patients were treated under general anesthesia. Our
technique consists of the following procedures: The sur-
face of the lesion was cooled by application of broken
pieces of ice, for 10–15 minutes prior to irradiation with
a Nd:YAG laser. The laser-induced coagulation was per-
formed in a repetitive manner with the hand-piece, of the
irradiation delivery system, being held perpendicular to
the skin with the lesion at its focal point. The laser beam
was guided through a piece of ice that was in direct contact
with the skin in order to protect the epidermis from the
thermal damage of irradiation. Moreover, compressing
the tissue with this piece of ice can increase the depth of
penetration of the laser beam. The laser power was be-
tween 35–45 W, with a pulse length of 2–10 seconds. La-
ser energy was delivered to all areas of the vascular lesion.
The average time for the laser photocoagulation proce-
dure varied from 15 to 30 minutes depending on the ex-
tent of the lesion. The session lasted until edema appeared
in the lesion, and its consistency became hard. After radi-
ation the lesion was protected with continuous applica-
tion of ice for 5–10 minutes. In all cases the patients wore
protective eye covering. A topical application of antibiotic
ointment was all that was necessary for the treated area.
The treatment results were assessed by measuring the
change in size of the lesion, and were classified as follows:
"Excellent" 90–100 % area reduction, "Good" 50–89%
area reduction, "Moderate" 20–49% area reduction, and
"Poor" 0–19% area reduction. In cases where the lesion
remained, after the first session of therapy, a second or
third session of therapy followed. Postoperatively, the pa-
tients were seen at 3 weeks, 6 weeks, 3 months, 6 months,
1 year and yearly thereafter.
Table 1: 
Height
Area A (1–2 cm) B (2–3 cm) C (>3 cm)
a (1–4 cm2) 72 8 -
b (4–10 cm2) 18 2 2
c (> 10 cm2) - 4 4Page 2 of 6
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The postoperative hospital stay for all patients ranged
from 1 to 2 days. Three weeks after treatment all lesions
appeared with edema and with a slightly hard consisten-
cy. The size of the lesions had decreased only slightly. At
the 6 week follow-up edema was no longer present, and
all lesions had decreased in size so as not to interfere with
vital functions. At the 6 month follow-up the results were
clinically evident (see Table 2) (Fig. 1). A second session
followed in 30 out of 38 patients in which, the initial re-
sults were good, moderate, or poor. The parents of the re-
maining eight children refused this second session either
because of social inconvenience (six children), or because
they were disappointed with the initial results (two chil-
dren) and these patients dropped out from the study. Six
months after the second session 24 of these patients had
excellent results and six patients had moderate results
(Fig. 2). A third session followed for these six patients. Six
months after the third session the results were good in all
Figure 1
a) Superficial hemangioma on the right periorbital region in a 5-month-old girl. b) Clinical response after one session with a 
Nd:YAG photocoagulation.
Figure 2
a) Massine hemangiomas on the left hand in a 6-month-old girl. b) Regression after three Nd:YAG laser treatments.Page 3 of 6
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(8.8%) patients. One patient had postoperative bleeding,
which stopped spontaneously within 1 hour. Atrophic
scars occurred in six patients (5.8%). In three of them the
scars appeared after the second session and were small in
size; a surgical excision was performed with good results.
In the other three the scars presented after the third ses-
sion and were large in size; no surgical excision was done.
Large hypertrophic scars occurred in two patients (1.9%)
after the third session; no surgical excision was
accomplished.
Discussion
Most hemangiomas do not require treatment, as most of
them resolve spontaneously. Batta et al reported a series of
121 infants with early haemangiomas. They observed that
about 40% of these showed complete clearance or mini-
mal residual sign at the age of 1 year without treatment
[11]. Nevertheless, some complications are indications
for therapy. A number of treatment modalities have been
proposed for the treatment of hemangiomas, including:
systemic therapy with corticosteroids, interferon-a2a, sur-
gical procedures, compression, sclerosis treatment,
embolization, intralesional injection of corticosteroids,
and cryotherapy [6,12–16].
One of the most significant advances in the treatment of
hemangiomas has been the advent of laser technology,
and its clinical application in pediatric surgery at the end
of 1960's [17]. Since then, there have been many reports
of the treatment of these lesions using different types of la-
ser, including the argon, CO2, the Nd:YAG laser, the flash
lamp-pumped pulsed dye laser (FPDL) and more recently
the long-pulsed tunable dye laser (LPTDL) [18,19]. The
FPDL is recommended as the most effective treatment for
port-wine stains and superficial skin teleangiectasia
[5,7,20]. Satisfactory results have also been obtained with
argon laser [21]. Nevertheless, the restricted effective
depth (of only 1–2 mm), and the rather non-specific
coagulation of vascular lesion associated, with a risk scar-
ing limits, the use of the argon laser in children. [22].
Although most authors agree that the initial therapeutic
modality in the management of hemangiomas should be
the administration of corticosteroids (systemic or intersti-
tial) [23,24], some others have questioned their efficacy
[25]. We did not use corticosteroid therapy as there are
Figure 3
a) Ulcerated and bleeding hemangioma on the right side of cheek in a 4-month-old boy. b) The same patient after two treat-
ments with a Nd:YAG laser.Page 4 of 6
(page number not for citation purposes)
BMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/2well-documented risks, such as disseminated varicella and
herpes infection. The major adverse effects of the corticos-
teroids (growth retardation, cushingoid characteristics)
are also a reasons to limit their use in children.
Landthaler et al. reported a series of hemangiomas treated
with different types of lasers. They observed that in the su-
perficial hemangiomas the results with the FPDL were ex-
cellent or good, but in the deep part of the lesion was not
influenced by the FPDL [7]. They concluded that the
Nd:YAG laser is the treatment modality of choice for thick
hemangiomas. We have chosen the Nd:YAG laser as a
therapeutic modality because its irradiation penetrates ap-
proximately 8 mm into soft tissue, and the scattering in
the tissue effects deep photocoagulation.
There are several methods of cooling utilized with laser
treatment including cryogen spray cooling, contact cool-
ing incorporated into laser hand-pieces and air cooling
[19,26,27]. In our special therapeutic technique we used
ice to prevent laser-induced thermal injury to the epider-
mis, but modified the methods of other authors, who
cooled the lesions with cryogen spray prior and during ac-
tual irradiation [28,29]. Our cooling of the surface of the
lesion with application of broken pieces of ice prior to ir-
radiation, provoked vasoconstriction of superficial vessels
with consequent diminution of blood in these, which in
turn helped to diminish the absorption of laser beam, and
minimized adverse thermal effects on the skin. During ir-
radiation we used a piece of ice to protect the epidermis
and compress the lesion, which helped the beam to pene-
trate and induce photocoagulation in the deep layers of
the lesion, thus producing even better results. Also, imme-
diately after irradiation we protected the surface of lesion
with ice because the increased residual temperature can
provoke, thermal damage. Our use of ice produced excel-
lent clinical and cosmetic results in the treatment of he-
mangiomas with a Nd:YAG laser, in contrast to Landthaler
et al. who observed superficial scarring in all patients
treated by a Nd : YAG laser. They used an output power of
50 W with exposure time of up to 1 second [7]. They per-
formed coagulation in four infants (aged 4-months to 14-
months) and observed regression of the lesions in three of
them. The fourth child, an 11-month-old girl with a pul-
sating extensive hemangioma of the lower tip, treated
with two laser sessions with no effect on the size of
hemangioma. Lesions in this series were very similar in 10
patients included in our study. Our results were excellent
in all of them. Moreover, we treated an hemangioma sim-
ilar to the above described hemangioma of the 11-month-
old girl with excellent results.
Our results clearly demonstrate the ability of the Nd:YAG
laser to successfully treat cutaneous hemangiomas of var-
ious sizes. In small and shallow (height <2 cm, area <4
cm2) hemangiomas we have obtained excellent results af-
ter only one session of laser treatment. Larger and deeper
hemangiomas (height > 2 cm, area > 4 cm2) were reduced
by approximately 50% during the first session, while for
the residual lesion a second or third session was needed to
achieve excellent results, contrasting the results of Clymer
et al. who reported an average of approximately five treat-
ments to achieve the final result [3]. They used interstitial
Nd:YAG coagulation in eight children with hemangiomas
aged 2 months to 8 years. The power settings were be-
tween 15 and 25 W, with a pulse length of 0.3 to 1.0 sec-
onds. They observed regression in the size of









Area Good 15 (83,33%) 1 (50%)
Moderate 3 (16,67%) 1 (50%) 1 (50%)
Poor 1 (50%)
c (>10 cm2)
Moderate 2 (50%) 2 (50%)
Poor 2 (50%) 2 (50%)
Excellent: 90 to 100 percent reduction. Good: 50 to 89 percent reduction. Moderate: 20 to 49 percent reduction. Poor: 0 to 19 percent reduction.Page 5 of 6
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tient were required to obtain optimal results. When the 72
patients with small and shallow hemangiomas (height <
2 cm, area < 4 cm2) were removed from the analysis the
remaining 30 patients needed an average of 2.2 treat-
ments to achieve the end results. We believe that the ice
cooling of the epidermis with manual compression of ice
cube upon the lesion permitted us to increase the power
setting, the exposure time, and the depth of penetration of
the laser beam.
We conclude that use of the Nd:YAG laser in conjunction
with ice protection of the epidermis is a very useful instru-
ment in the treatment of massive and deep hemangiomas
(height > 2 cm, area > 4 cm2) in childhood, in terms of
minimizing the adverse thermal effects on the skin, and
decreasing the number of sessions required to treat these
lesions.
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